Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 25, 2024Cardiovascular DiabetologyOpen Access

Association of sodium-glucose cotransporter 2 inhibitors with risk of major adverse cardiovascular events in type 2 diabetes patients with acute coronary syndrome: a propensity score‑matched analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

TLTao LiuZFZeyuan FanBXBing Xiao

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2024) studied this question.

synapsesocial.com/papers/68e72644b6db6435876a02e4https://doi.org/10.1186/s12933-024-02200-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Combination treatment of SGLT2i and GLP-1RA associated with improved cardiovascular outcomes in type 2 diabetes patients with acute coronary syndrome: A propensity score-matched cohort study2025 · 20 citations
  2. 2Clinical Outcomes in Type 2 Diabetes Patients After Acute Myocardial Infarction: A Comparison of <scp>Sodium–Glucose</scp> Cotransporter 2 Inhibitors vs. <scp>Non‐Users</scp>2024 · 7 citations
  3. 3Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Acute Coronary Syndrome2024 · 2 citations
  4. 4Cardiovascular Risks With SGLT2 Inhibitors in Clinical Practice Among Patients With Type 2 Diabetes2024 · 5 citations
  5. 5Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease2022 · 83 citations